Published online before print October 5, 2006, doi: 10.1161/01.RES.0000248184.21644.20
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 9, 2006
Revised on September 21, 2006
Accepted on September 21, 2006
Cellular Mechanism Through Which Parathyroid Hormone-Related Protein Induces Proliferation in Arterial Smooth Muscle Cells. Definition of an Arterial Smooth Muscle PTHrP/p27kip1 Pathway
Nathalie Fiaschi-Taesch *;
From the Division of Endocrinology (N.F.-T., B.M.S., K.U., T.B., K.K.T., I.C.-C., A.B., A.F.S.), University of Pittsburgh School of Medicine, Pa; and Department of Pharmacology and Experimental Therapeutics (B.L.), University of Florida, Gainesville.
* To whom correspondence should be addressed. E-mail: Taeschn{at}msx.dept-med.pitt.edu.
Parathyroid hormone-related protein (PTHrP) is present in vascular smooth muscle (VSM), is markedly upregulated in response to arterial injury, is essential for normal VSM proliferation, and also markedly accentuates neointima formation following rat carotid angioplasty. PTHrP contains a nuclear localization signal (NLS) through which it enters the nucleus and leads to marked increases in retinoblastoma protein (pRb) phosphorylation and cell cycle progression. Our goal was to define key cell cycle molecules upstream of pRb that mediate cell cycle acceleration induced by PTHrP. The cyclin D/cdk-4,-6 system and its upstream regulators, the inhibitory kinases (INKs), are not appreciably influenced by PTHrP. In striking contrast, cyclin E/cdk-2 kinase activity is markedly increased by PTHrP, and this is a result of a specific, marked, PTHrP-induced proteasomal degradation of p27kip1. Adenoviral restoration of p27kip1 fully reverses PTHrP-induced cell cycle progression, indicating that PTHrP mediates its cell cycle acceleration in VSM via p27kip1. In confirmation, adenoviral delivery of PTHrP to murine primary vascular smooth muscle cells (VSMCs) significantly decreases p27kip1 expression and accelerates cell cycle progression. p27kip1 is well known to be a central cell cycle regulatory molecule involved in both normal and pathological VSM proliferation and is a target of widely used drug-eluting stents. The current observations define a novel "PTHrP/p27kip1 pathway" in the arterial wall and suggest that this pathway is important in normal arterial biology and a potential target for therapeutic manipulation of the arterial response to injury.
Key words: cell cycle progression • p27Kip1/pRb • proliferation • PTHrP • vascular smooth muscle cell proliferation
This article has been cited by other articles:
 |
|
 |
|
  G. J. Song, N. Fiaschi-Taesch, and A. Bisello Endogenous Parathyroid Hormone-Related Protein Regulates the Expression of PTH Type 1 Receptor and Proliferation of Vascular Smooth Muscle Cells Mol. Endocrinol., October 1, 2009; 23(10): 1681 - 1690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Fiaschi-Taesch, B. Sicari, K. Ubriani, I. Cozar-Castellano, K. K. Takane, and A. F. Stewart Mutant Parathyroid Hormone-Related Protein, Devoid of the Nuclear Localization Signal, Markedly Inhibits Arterial Smooth Muscle Cell Cycle and Neointima Formation by Coordinate Up-Regulation of p15Ink4b and p27kip1 Endocrinology, March 1, 2009; 150(3): 1429 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Miao, H. Su, B. He, J. Gao, Q. Xia, M. Zhu, Z. Gu, D. Goltzman, and A. C. Karaplis Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein PNAS, December 23, 2008; 105(51): 20309 - 20314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Fiaschi-Taesch, D. M. Berman, B. M. Sicari, K. K. Takane, A. Garcia-Ocana, C. Ricordi, N. S. Kenyon, and A. F. Stewart Hepatocyte Growth Factor Enhances Engraftment and Function of Nonhuman Primate Islets Diabetes, October 1, 2008; 57(10): 2745 - 2754. [Abstract] [Full Text] [PDF]
|
|